Women’s Genome Health Study

Overview

Acronym
WGHS
Investigators
  • Dr. Daniel I. Chasman

    Brigham and Women's Hospital

Contacts
  • Dr. Daniel I. Chasman

    Brigham and Women's Hospital

General Design

Study design
Cohort
Start Year
2006
General Information on Follow Up (profile, frequency)

Ongoing DNA analyses from the participants' blood sample provided at baseline (1992-1995) of the WHS study.

Recruitment Target
  • Individuals
Number of Participants
28,345
Number of Participants with Biological Samples
28,345

Access

Availability of data and biosamples

Possible Access to Data
Possible Access to Biosamples
Other

Marker Paper

Ridker PM, Chasman DI, Zee RY, Parker A, et al. Rationale, design, and methodology of the Women's Genome Health Study: a genome-wide association study of more than 25,000 initially healthy american women. Clinical Chemistry, 2008; 54(2): 249-55.

PUBMED 18070814

Timeline

Population

WGHS population

Selection Criteria

Gender
Women only
Minimum age
45
Countries
  • United States of America

Sources of Recruitment

Participants from Existing Studies
  • Women's Health Study
Supplementary Information

All members of the WGHS cohort were participants in the WHS who provided an adequate baseline blood sample for plasma and DNA analysis and who gave consent for blood-based analyses and long-term follow-up.

Sample Size

Number of Participants
28,345
Number of Participants with Biological Samples
28,345

Data Collection Events

# Name Description Start End
0 WGHS analyses 2006 (October) 2014 (December)

Individual Studies Included

Acronym Name Study design Participants Countries

Harmonization Projects Included

Acronym Name

Networks

Acronym Name Studies

Datasets

Name Type Data Collection Events Variables
Last Update: 2020-02-05 16:08